HealthDay on MSN14h
Use of Parallel Transmit 7T MRI Changes Management for Epilepsy Surgery
Parallel transmit (pTx) 7 Tesla (T) magnetic resonance imaging (MRI) changes management in more than half of adult candidates for epilepsy surgery, according to a study published online March 20 in ...
Johns Hopkins Medicine1d
Baltimore Student-Athlete Is Winning Match Against Multiple Sclerosis
Gabryelle “Gabby” Scholfield, a 16-year-old student-athlete at Edmondson Westside High School in Baltimore, who plays center ...
Pharmabiz2d
US FDA accepts for priority review Sanofi’s regulatory submission of tolebrutinib for patients with multiple sclerosis
US FDA accepts for priority review Sanofi’s regulatory submission of tolebrutinib for patients with multiple sclerosis: Paris Wednesday, March 26, 2025, 09:00 Hrs [IST] The US F ...
Applied Clinical Trials Online2d
Results of Phase III HERCULES, GEMINI 1 and 2 Trials Lead to FDA Priority Review for Tolebrutinib for Non-Relapsing Secondary Progressive MS
FDA grants Priority Review status to Sanofi's tolebrutinib for the treatment of non-relapsing secondary progressive multiple ...
PharmiWeb2d
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to ...
Sanofi: Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis If approved, tolebrutinib would be the first and only brain-penetrant BTK inhibitor to ...
MedPage Today3d
Deciding Whether Multiple Sclerosis Treatment Should Be Discontinued
Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...
Live Science on MSN4d
In a 1st, trial finds vitamin D supplements may slow multiple sclerosis. But questions remain.
A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...
Everyone thought I was tired, turns out I had a brain disease
Multiple sclerosis (MS) is a condition that affects the brain and spinal cord. Some of the most common symptoms include ...
Medscape7d
Can Central Vein Sign Distinguish Multiple Sclerosis From Its Most Common Mimic?
Using 3T MRI to analyze central vein counts and distribution in white matter lesions allows investigators to distinguish ...
Physician's Weekly8d
Benefits of HSCT in MS Should Be Weighed Against Impact on Cognition
Research showed that HSCT in MS was associated with long-term improvements in quality of life but may cause short-term cognitive decline post-treatment.